These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 7607786

  • 1. Long-term therapy with 5-aminosalicylic acid in Crohn's disease: is it useful? Our four years experience.
    Bresci G, Parisi G, Banti S.
    Int J Clin Pharmacol Res; 1994; 14(4):133-8. PubMed ID: 7607786
    [Abstract] [Full Text] [Related]

  • 2. 5-aminosalicylic acid in the prevention of relapses of Crohn's disease in remission: a long-term study.
    Bresci G, Petrucci A, Banti S.
    Int J Clin Pharmacol Res; 1991; 11(4):200-2. PubMed ID: 1813439
    [Abstract] [Full Text] [Related]

  • 3. [5-Aminosalicylic acid in the prevention of recurrences of Crohn's disease].
    Del Corso L, Moruzzo D, Romanelli AM, Norpoth M, Pentimone F, Bresci G.
    Dtsch Med Wochenschr; 1995 Dec 15; 120(50):1723-7. PubMed ID: 8542807
    [Abstract] [Full Text] [Related]

  • 4. Coated oral 5-aminosalicylic acid versus placebo in maintaining remission of inactive Crohn's disease. International Mesalazine Study Group.
    Aliment Pharmacol Ther; 1990 Feb 15; 4(1):55-64. PubMed ID: 2104074
    [Abstract] [Full Text] [Related]

  • 5. Comparison between high dose 5-aminosalicylic acid and 6-methylprednisolone in active Crohn's ileocolitis. A multicenter randomized double-blind study. German 5-ASA Study Group.
    Gross V, Andus T, Fischbach W, Weber A, Gierend M, Hartmann F, Schölmerich J.
    Z Gastroenterol; 1995 Oct 15; 33(10):581-4. PubMed ID: 7502549
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Oral mesalazine for the treatment of Crohn's disease: clinical efficacy with respect to pharmacokinetic properties.
    Tromm A, Griga T, May B.
    Hepatogastroenterology; 1999 Oct 15; 46(30):3124-35. PubMed ID: 10626173
    [Abstract] [Full Text] [Related]

  • 8. [Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease].
    Nos P, Hinojosa J, Aguilera V, Molés JR, Pastor M, Ponce J, Berenguer J.
    Gastroenterol Hepatol; 2000 Oct 15; 23(8):374-8. PubMed ID: 11227650
    [Abstract] [Full Text] [Related]

  • 9. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease.
    Mantzaris GJ, Petraki K, Sfakianakis M, Archavlis E, Christidou A, Chadio-Iordanides H, Triadaphyllou G.
    Clin Gastroenterol Hepatol; 2003 Mar 15; 1(2):122-8. PubMed ID: 15017504
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).
    Colombel JF, Lémann M, Cassagnou M, Bouhnik Y, Duclos B, Dupas JL, Notteghem B, Mary JY.
    Am J Gastroenterol; 1999 Mar 15; 94(3):674-8. PubMed ID: 10086650
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's disease.
    Thia KT, Sandborn WJ, Lewis JD, Loftus EV, Feagan BG, Steinhart AH, Hanauer SB, Persson T, Sands BE.
    Am J Gastroenterol; 2008 Dec 15; 103(12):3123-31. PubMed ID: 18786111
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Review article: chronic active disease and maintaining remission in Crohn's disease.
    Kamm MA.
    Aliment Pharmacol Ther; 2004 Oct 15; 20 Suppl 4():102-5. PubMed ID: 15352904
    [Abstract] [Full Text] [Related]

  • 16. Epidemiological and clinical features of Spanish patients with Crohn's disease. Spanish Epidemiological and Economic Study Group on Crohn's disease.
    Eur J Gastroenterol Hepatol; 1999 Oct 15; 11(10):1121-7. PubMed ID: 10524641
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study.
    d'Albasio G, Pacini F, Camarri E, Messori A, Trallori G, Bonanomi AG, Bardazzi G, Milla M, Ferrero S, Biagini M, Quaranta S, Amorosi A.
    Am J Gastroenterol; 1997 Jul 15; 92(7):1143-7. PubMed ID: 9219787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.